Angiotensin converting enzyme inhibitors (ACEIs) are associated with an increased risk of lung cancer, according to an observational study that compared the blood pressure lowering drugs with angiotensin receptor blockers. While the risk for individuals was ‘modest’ the small relative effects seen in their study “could translate into large absolute numbers of patients at risk,” ...
Study casts shadow over long term safety of ACE inhibitors
By Nicola Garrett
24 Oct 2018